Tumor Immunology and Immunotherapy 2017 Scientific Poster Session

Involvement of commensal microbiota in aPD-1-mediated antitumor activity in a preclinical tumor model

Poster Session: Poster Session A
Session Date and Time: Monday, October 2, 5:30 p.m. to 7:30 p.m.
Location: Back Bay
Poster Board Number: A05

read-poster.png

The landscape of CD47 expression in tumor cells predicts macrophage-mediated phagocytosis in immuno-oncology therapy

Poster Session: Poster Session A
Session Date and Time: Monday, October 2, 5:30 p.m. to 7:30 p.m.
Location: Back Bay
Poster Board Number: A49

read-poster.png

MiXeno™ is an efficient platform to evaluate the in vivo activity of human antitumor immunotherapeutics

Poster Session: Poster Session B
Session Date and Time: Tuesday, October 3, 12:00 p.m. to 2:30 p.m.
Location: Back Bay
Poster Board Number: B28

read-poster.png

Collaborative Posters

Preclinical evaluation of niraparib in combination with anti-PD-1/anti-PD-L1 in mouse-derived syngeneic transplant models

Authors: Sarah Wang1, Yonghong Xiao1, Kaiming Sun1, Keith Mikule1, XiaoYan Ma2, Ningping Feng2, Christopher P. Vellano3, Lorenzo Federico3, Lily Tong4, Tingting Li4, Davy Ouyang4, Joseph R. Marszalek2, Gordon B. Mills3, Sridhar Ramaswamy1, Jeffery Hanke1 and Jing Wang1

1TESARO Inc., Waltham MA USA.
2IACS, The University of Texas MD Anderson Cancer Center, Houston, TX USA.
3Dept of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX USA.
4Crown Bioscience Inc., Taicang, Jiangsu

Poster Session: Poster Session B
Session Date and Time: Tuesday, October 3, 12:00 p.m. to 2:30 p.m.
Location: Back Bay
Poster Board Number: B16

 

Request Time To Discuss a Poster

Your privacy is important to us.
We'll never share your information.

SHARE THIS